Clinical Trials Logo

Clinical Trial Summary

To validate the 2 questionnaires ZARIT-12 and CBI it is important to go through several stages: 1. translation stage : during this stage there will be a meeting of experts to Validate the test version in French by 4 Bilingual translators of the French and English mother tongue. 2. pilot stage : recruit a number of 30 neurological patients' caregivers, in order to validate the comprehension, thus obtaining the final version of the questionnaire. 3. Validation stage : the two questionnaires have been validated, in this stage there should be a recruitment of 264 participants for the CBI questionnaire and 120 participants for the ZARIT-12 questionnaire, and these 2 questionnaires will be deliver to the participant on the same day. - The first questionnary will have to be filled the day they get the questionnary (day 1). - The second one must be completed and sent fourteen days later (day 14).


Clinical Trial Description

To validate the 2 questionnaires ZARIT-12 and CBI it is important to go through several stages: 1. translation stage : during this stage there will be a meeting of experts to Validate the test version in French by 4 Bilingual translators of the French and English mother tongue. 2. pilot stage : recruit a number of 30 neurological patients' caregivers, in order to validate the comprehension, thus obtaining the final version of the questionnaire. 3. Validation stage : the two questionnaires have been validated, in this stage there should be a recruitment of 264 participants for the CBI questionnaire and 120 participants for the ZARIT-12 questionnaire, and these 2 questionnaires will be deliver to the participant on day 1. The first questionnary will have to be filled on day 1 and the second one must be completed and sent fourteen days later (so on day 14) ;


Study Design


NCT number NCT05978245
Study type Observational
Source Centre Hospitalier de Saint-Denis
Contact TURMEL Nicolas
Phone 0142356140
Email nicolas.turmel@ch-stdenis.fr
Status Recruiting
Phase
Start date November 22, 2023
Completion date December 31, 2024